Quercetin exerts cardiovascular protective effects in LPS-induced dysfunction in vivo by regulating inflammatory cytokine expression, NF-κB phosphorylation, and caspase activity

Molecular and Cellular Biochemistry

Volumn 446, Issue 1-2, 2018, Pages 43-52

  Wei, Xiqing ^a,b   Meng, Xiangli ^c   Yuan, Yuxiang ^c   Shen, Fengjuan ^c   Li, Chengqiu ^c   Yang, Jun ^a  

^a QINGDAO UNIVERSITY   (China)

^b JINING MEDICAL UNIVERSITY   (China)

^c Zoucheng People s Hospital   (China)

Author keywords

Apoptotic pathway; LPS; Myocardial dysfunction; Nuclear factor I B ; Quercetin

Indexed keywords

CASPASE 3; CASPASE 7; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; NITRIC OXIDE; QUERCETIN; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR; CARDIOTONIC AGENT; IL1B PROTEIN, MOUSE; LIPOPOLYSACCHARIDE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BIOCHEMICAL ANALYSIS; CARDIAC MUSCLE CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME ACTIVITY; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PROTECTION; IN VIVO STUDY; INFLAMMATORY INFILTRATE; LIPOPOLYSACCHARIDE-INDUCED INFLAMMATION; M MODE ECHOCARDIOGRAPHY; MALE; MOUSE; MYOCARDIAL DISEASE; NONHUMAN; PROTEIN PHOSPHORYLATION; SYSTOLIC DYSFUNCTION; ANIMAL; BAGG ALBINO MOUSE; CARDIAC MUSCLE; CHEMICALLY INDUCED; DRUG EFFECT; GENE EXPRESSION REGULATION; INFLAMMATION; METABOLISM; PATHOLOGY; SEPSIS;

ANIMALS; APOPTOSIS; CARDIOTONIC AGENTS; GENE EXPRESSION REGULATION; INFLAMMATION; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; MYOCARDIUM; NF-KAPPA B; QUERCETIN; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85040321710     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-018-3271-6     Document Type: Article

References (34)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310
2. Becker JU, Theodosis C, Jacob ST, Wira CR, Groce NE (2009) Surviving sepsis in low-income and middle-income countries: new directions for care and research. Lancet Infect Dis 9:577–582. 10.1016/S1473-3099(09)70135-5
3. Hall MW, Geyer SM, Guo CY, Panoskaltsis-Mortari A, Jouvet P, Ferdinands J, Shay DK, Nateri J, Greathouse K, Sullivan R, Tran T, Keisling S, Randolph AG, Pediatric Acute Lung I and Sepsis Investigators Network PSI (2013) Innate immune function and mortality in critically ill children with influenza: a multicenter study. Crit Care Med 41:224–236. 10.1097/CCM.0b013e318267633c
4. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD 2nd, Kreisel D, Krupnick AS, Srivastava A, Swanson PE, Green JM, Hotchkiss RS (2011) Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306:2594–2605. 10.1001/jama.2011.1829
5. Drewry AM, Samra N, Skrupky LP, Fuller BM, Compton SM, Hotchkiss RS (2014) Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock 42:383–391. 10.1097/SHK.0000000000000234
6. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R, Surviving Sepsis Campaign Guidelines Committee including the Pediatric S (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:580–637. 10.1097/CCM.0b013e31827e83af
7. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, Ognibene FP (1990) Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113:227–242
8. Niu J, Azfer A, Kolattukudy PE (2008) Protection against lipopolysaccharide-induced myocardial dysfunction in mice by cardiac-specific expression of soluble Fas. J Mol Cell Cardiol 44:160–169. 10.1016/j.yjmcc.2007.09.016
9. Charpentier J, Luyt CE, Fulla Y, Vinsonneau C, Cariou A, Grabar S, Dhainaut JF, Mira JP, Chiche JD (2004) Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 32:660–665
10. Zaky A, Deem S, Bendjelid K, Treggiari MM (2014) Characterization of cardiac dysfunction in sepsis: an ongoing challenge. Shock 41:12–24. 10.1097/SHK.0000000000000065
11. Lu J, Zheng YL, Luo L, Wu DM, Sun DX, Feng YJ (2006) Quercetin reverses D-galactose induced neurotoxicity in mouse brain. Behav Brain Res 171:251–260. 10.1016/j.bbr.2006.03.043
12. Molina MF, Sanchez-Reus I, Iglesias I, Benedi J (2003) Quercetin, a flavonoid antioxidant, prevents and protects against ethanol-induced oxidative stress in mouse liver. Biol Pharm Bull 26:1398–1402
13. Yang T, Kong B, Gu JW, Kuang YQ, Cheng L, Yang WT, Xia X, Shu HF (2014) Anti-apoptotic and anti-oxidative roles of quercetin after traumatic brain injury. Cell Mol Neurobiol 34:797–804. 10.1007/s10571-014-0070-9
14. Beckmann DV, Carvalho FB, Mazzanti CM, Dos Santos RP, Andrades AO, Aiello G, Rippilinger A, Graca DL, Abdalla FH, Oliveira LS, Gutierres JM, Schetinger MR, Mazzanti A (2014) Neuroprotective role of quercetin in locomotor activities and cholinergic neurotransmission in rats experimentally demyelinated with ethidium bromide. Life Sci 103:79–87. 10.1016/j.lfs.2014.03.033
15. Qu X, Qi D, Dong F, Wang B, Guo R, Luo M, Yao R (2014) Quercetin improves hypoxia-ischemia induced cognitive deficits via promoting remyelination in neonatal rat. Brain Res 1553:31–40. 10.1016/j.brainres.2014.01.035
16. Jin HB, Yang YB, Song YL, Zhang YC, Li YR (2012) Protective roles of quercetin in acute myocardial ischemia and reperfusion injury in rats. Mol Biol Rep 39:11005–11009. 10.1007/s11033-012-2002-4
17. Wan LL, Xia J, Ye D, Liu J, Chen J, Wang G (2009) Effects of quercetin on gene and protein expression of NOX and NOS after myocardial ischemia and reperfusion in rabbit. Cardiovasc Ther 27:28–33. 10.1111/j.1755-5922.2009.00071.x
18. Bartekova M, Carnicka S, Pancza D, Ondrejcakova M, Breier A, Ravingerova T (2010) Acute treatment with polyphenol quercetin improves postischemic recovery of isolated perfused rat hearts after global ischemia. Can J Physiol Pharmacol 88:465–471. 10.1139/y10-025
19. Casey LC, Balk RA, Bone RC (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119:771–778
20. Debets JM, Kampmeijer R, van der Linden MP, Buurman WA, van der Linden CJ (1989) Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med 17:489–494
21. Rudiger A, Singer M (2007) Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 35:1599–1608. 10.1097/01.CCM.0000266683.64081.02
22. Wang X, Zingarelli B, O’Connor M, Zhang P, Adeyemo A, Kranias EG, Wang Y, Fan GC (2009) Overexpression of Hsp20 prevents endotoxin-induced myocardial dysfunction and apoptosis via inhibition of NF-kappaB activation. J Mol Cell Cardiol 47:382–390. 10.1016/j.yjmcc.2009.05.016
23. Coalson JJ, Hinshaw LB, Guenter CA, Berrell EL, Greenfield LJ (1975) Pathophysiologic responses of the subhuman primate in experimental septic shock. Lab Invest 32:561–569
24. Hersch M, Gnidec AA, Bersten AD, Troster M, Rutledge FS, Sibbald WJ (1990) Histologic and ultrastructural changes in nonpulmonary organs during early hyperdynamic sepsis. Surgery 107:397–410
25. Gotloib L, Shostak A, Galdi P, Jaichenko J, Fudin R (1992) Loss of microvascular negative charges accompanied by interstitial edema in septic rats’ heart. Circ Shock 36:45–56
26. Solomon MA, Correa R, Alexander HR, Koev LA, Cobb JP, Kim DK, Roberts WC, Quezado ZM, Scholz TD, Cunnion RE et al (1994) Myocardial energy metabolism and morphology in a canine model of sepsis. Am J Physiol 266:H757–H768
27. Goddard CM, Allard MF, Hogg JC, Walley KR (1996) Myocardial morphometric changes related to decreased contractility after endotoxin. Am J Physiol 270:H1446–H1452
28. Lancel S, Joulin O, Favory R, Goossens JF, Kluza J, Chopin C, Formstecher P, Marchetti P, Neviere R (2005) Ventricular myocyte caspases are directly responsible for endotoxin-induced cardiac dysfunction. Circulation 111:2596–2604. 10.1161/CIRCULATIONAHA.104.490979
29. Kumar A, Krieger A, Symeoneides S, Kumar A, Parrillo JE (2001) Myocardial dysfunction in septic shock: Part II. Role of cytokines and nitric oxide. J Cardiothorac Vasc Anesth 15:485–511. 10.1053/jcan.2001.25003
30. Wu QL, Shen T, Ma H, Wang JK (2012) Sufentanil postconditioning protects the myocardium from ischemia-reperfusion via PI3K/Akt-GSK-3beta pathway. J Surg Res 178:563–570. 10.1016/j.jss.2012.05.081
31. Brown MA, Jones WK (2004) NF-kappaB action in sepsis: the innate immune system and the heart. Front Biosci 9:1201–1217
32. Baumgarten G, Knuefermann P, Nozaki N, Sivasubramanian N, Mann DL, Vallejo JG (2001) In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4. J Infect Dis 183:1617–1624. 10.1086/320712
33. Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE (1996) Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183:949–958
34. Yao RQ, Qi DS, Yu HL, Liu J, Yang LH, Wu XX (2012) Quercetin attenuates cell apoptosis in focal cerebral ischemia rat brain via activation of BDNF-TrkB-PI3K/Akt signaling pathway. Neurochem Res 37:2777–2786. 10.1007/s11064-012-0871-5